Quantification of airborne SARS-CoV-2 genomic particles in different hospital settings
- PMID: 34711888
- PMCID: PMC8553841
- DOI: 10.1038/s41598-021-00761-1
Quantification of airborne SARS-CoV-2 genomic particles in different hospital settings
Abstract
We quantified the presence of SARS-CoV-2 RNA in the air of different hospital settings and the autopsy room of the largest medical centre in Sao Paulo, Brazil. Real-time reverse-transcription PCR was used to determine the presence of the envelope protein of SARS-CoV-2 and the nucleocapsid protein genes. The E-gene was detected in 5 out of 6 samples at the ICU-COVID-19 ward and in 5 out of 7 samples at the ward-COVID-19. Similarly, in the non-dedicated facilities, the E-gene was detected in 5 out of 6 samples collected in the ICU and 4 out of 7 samples in the ward. In the necropsy room, 6 out of 7 samples were positive for the E-gene. When both wards were compared, the non-COVID ward presented a significantly higher concentration of the E-gene than in the COVID-19 ward (p = 0.003). There was no significant difference in E-gene concentration between the ICU-COVID-19 and the ICU (p = 0.548). Likewise, there was no significant difference among E-gene concentrations found in the autopsy room versus the ICUs and wards (dedicated or not) (p = 0.245). Our results show the widespread presence of aerosol contamination in different hospital units.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- WHO, World Health Organization. Coronavirus Disease (COVID-2019) Situation Reports (2021). www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (Accessed April 2021).
-
- JHU, Johns Hopkins University. New COVID-19 Cases Worldwide: Coronavirus Resource Center (2021). https://coronavirus.jhu.edu/data/new-cases (Accessed April 2021).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous